https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Acta Oncol 2009;48(3):452-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Acta Oncol 2009;48(3):452-62009-01-01 00:00:002009-01-01 00:00:00Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Semin. Hematol. 2009 Jan;46(1):89-99
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Semin. Hematol. 2009 Jan;46(1):89-992009-01-01 00:00:002019-02-15 08:32:28Immunotherapy in acute leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Semin. Hematol. 2009 Jan;46(1):76-88
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Semin. Hematol. 2009 Jan;46(1):76-882009-01-01 00:00:002019-02-15 08:32:29New therapeutic strategies in acute lymphoblastic leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Handb Exp Pharmacol 2009;(188):319-48
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Handb Exp Pharmacol 2009;(188):319-482009-01-01 00:00:002019-02-15 08:32:29Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):25-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):25-82009-01-01 00:00:002019-02-15 08:38:02Recent advances in cancer immunotherapy with an emphasis on vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):51-66
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):51-662009-01-01 00:00:002021-11-15 17:02:36Randomized clinical studies of anti-tumor vaccination: state of the art in 2008
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Drugs 2009;69(3):241-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Drugs 2009;69(3):241-92009-01-01 00:00:002019-02-15 08:46:48Tumour vaccine approaches for CNS malignancies: progress to date
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Hepatology 2009 Jan;49(1):124-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Hepatology 2009 Jan;49(1):124-322009-01-01 00:00:002020-01-08 10:10:21A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Electromagn Biol Med 2009;28(2):148-65
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Electromagn Biol Med 2009;28(2):148-652009-01-01 00:00:002019-02-15 09:17:31Oncothermia treatment of cancer: from the laboratory to clinic
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-17 / Clin. Rheumatol. 2009 Apr;28(4):397-402
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-17 / Clin. Rheumatol. 2009 Apr;28(4):397-4022008-12-17 00:00:002019-02-15 09:17:37The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis
